Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 470

Similar articles for PubMed (Select 15887291)

1.

High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.

Riemersma SA, Oudejans JJ, Vonk MJ, Dreef EJ, Prins FA, Jansen PM, Vermeer MH, Blok P, Kibbelaar RE, Muris JJ, Schuuring EM, Kluin PM.

J Pathol. 2005 Jul;206(3):328-36.

PMID:
15887291
2.

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.

Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E, Kluin PM.

Blood. 2000 Nov 15;96(10):3569-77.

3.

Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.

Ryschich E, Autschbach F, Eisold S, Klar E, Buchler MW, Schmidt J.

Tissue Antigens. 2003 Jul;62(1):48-54.

PMID:
12859594
4.
5.

Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma.

Booman M, Douwes J, Glas AM, Riemersma SA, Jordanova ES, Kok K, Rosenwald A, de Jong D, Schuuring E, Kluin PM.

Clin Cancer Res. 2006 May 1;12(9):2698-705.

6.

Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.

Jordanova ES, Riemersma SA, Philippo K, Schuuring E, Kluin PM.

Int J Cancer. 2003 Jan 20;103(3):393-8.

PMID:
12471623
7.

Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.

Ryschich E, Nötzel T, Hinz U, Autschbach F, Ferguson J, Simon I, Weitz J, Fröhlich B, Klar E, Büchler MW, Schmidt J.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):498-504.

8.

Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.

Jordanova ES, Riemersma SA, Philippo K, Giphart-Gassler M, Schuuring E, Kluin PM.

Genes Chromosomes Cancer. 2002 Sep;35(1):38-48.

PMID:
12203788
9.

Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.

Hilders CG, Munoz IM, Nooyen Y, Fleuren GJ.

Gynecol Oncol. 1995 Jun;57(3):366-75.

PMID:
7774840
10.

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.

Booman M, Szuhai K, Rosenwald A, Hartmann E, Kluin-Nelemans H, de Jong D, Schuuring E, Kluin P.

J Pathol. 2008 Oct;216(2):209-17. doi: 10.1002/path.2399.

PMID:
18729069
11.
12.

The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.

Riemersma SA, Jordanova ES, Haasnoot GW, Drabbels J, Schuuring E, Schreuder GM, Kluin PM.

Hum Immunol. 2006 Apr-May;67(4-5):303-10. Epub 2006 Apr 7.

PMID:
16720210
13.
14.
15.

Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas.

Bagot M, Nikolova M, Schirm-Chabanette F, Wechsler J, Boumsell L, Bensussan A.

Ann N Y Acad Sci. 2001 Sep;941:31-8.

PMID:
11594580
16.

Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma.

Jordanova ES, Philippo K, Giphart MJ, Schuuring E, Kluin PM.

Immunogenetics. 2003 Jul;55(4):203-9. Epub 2003 May 17.

PMID:
12756506
17.

Intra-tumoral cytolytic cells: pattern of distribution in B-cell non Hodgkin s lymphoma.

Perambakam S, Naresh K, Nerurkar A, Nadkarni J.

Pathol Oncol Res. 2000;6(2):114-7.

18.

Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.

Nouri AM, Hussain RF, Oliver RT, Handy AM, Bartkova I, Bodmer JG.

Eur J Cancer. 1993;29A(13):1895-9.

PMID:
8260249
19.

Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.

Chaperot L, Delfau-Larue MH, Jacob MC, Molens JP, Roussel B, Agrawal S, Farcet JP, Gressin R, Sotto JJ, Bensa JC, Plumas J.

Exp Hematol. 1999 Jul;27(7):1185-93.

PMID:
10390194
20.

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.

Stopeck AT, Gessner A, Miller TP, Hersh EM, Johnson CS, Cui H, Frutiger Y, Grogan TM.

Clin Cancer Res. 2000 Oct;6(10):3904-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk